US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
AU3127900A
(en)
*
|
1998-12-23 |
2000-07-31 |
Du Pont Pharmaceuticals Company |
Thrombin or factor xa inhibitors
|
PT1159279E
(pt)
|
1999-03-09 |
2003-02-28 |
Upjohn Co |
4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais
|
EP1181296A1
(en)
*
|
1999-06-03 |
2002-02-27 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
CZ302775B6
(cs)
*
|
1999-06-23 |
2011-11-02 |
Sanofi - Aventis Deutschland GmbH |
Substituovaný benzimidazol
|
US6689883B1
(en)
|
1999-09-28 |
2004-02-10 |
Bayer Pharmaceuticals Corporation |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
WO2001058878A1
(en)
*
|
2000-02-09 |
2001-08-16 |
The Procter & Gamble Company |
2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury
|
US7977333B2
(en)
|
2000-04-20 |
2011-07-12 |
Bayer Healthcare Llc |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
ATE443518T1
(de)
|
2001-07-27 |
2009-10-15 |
Curis Inc |
Vermittler von igel-signalpfaden, zusammensetzungen und relevante verwendungszwecke
|
WO2003020728A1
(en)
|
2001-08-30 |
2003-03-13 |
Pharmacia & Upjohn Company |
4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
|
US6620810B2
(en)
|
2001-08-30 |
2003-09-16 |
Pharmacia & Upjohn Company |
4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
AR038118A1
(es)
|
2002-01-14 |
2004-12-29 |
Upjohn Co |
Compuestos derivados de la bencinamida del acido 7-oxo-4,7-dihidrotien[2,3-b[piridin-6-carboxilico 3-sustituido que son utiles como antivirales
|
AR038294A1
(es)
|
2002-01-14 |
2005-01-12 |
Upjohn Co |
Oxotieno(3,2-b)piridincarboxamidas como agentes antivirales
|
AR038117A1
(es)
|
2002-01-14 |
2004-12-29 |
Upjohn Co |
Agentes antivirales derivados de la 4- oxo-4,7 -dihidrofuro [2,3-b]piridin-5-carboxamida
|
US7271179B2
(en)
*
|
2002-05-06 |
2007-09-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of JAK protein kinase
|
ATE323702T1
(de)
|
2002-08-06 |
2006-05-15 |
Astrazeneca Ab |
Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
|
IL154306A0
(en)
*
|
2003-02-05 |
2003-09-17 |
Rimonyx Pharmaceuticals Ltd |
Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof
|
JP2007536301A
(ja)
*
|
2004-05-04 |
2007-12-13 |
エフ.ホフマン−ラ ロシュ アーゲー |
Ikk阻害剤としてのチエノピリダジン
|
RU2006142741A
(ru)
*
|
2004-05-04 |
2008-06-10 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Тиенопиридины как ингибиторы ikk
|
US20060074102A1
(en)
*
|
2004-05-14 |
2006-04-06 |
Kevin Cusack |
Kinase inhibitors as therapeutic agents
|
US7714130B2
(en)
|
2004-06-17 |
2010-05-11 |
Wyeth |
Processes for preparing gonadotropin releasing hormone receptor antagonists
|
BRPI0512261A
(pt)
|
2004-06-17 |
2008-02-26 |
Wyeth Corp |
antagonistas de receptor de hormÈnio liberador de gonadotropina
|
RU2007107167A
(ru)
|
2004-07-30 |
2008-09-10 |
Метилджин, Инк. (Ca) |
Ингибиторы передачи сигнала рецептора vegf и рецептора hgf
|
AR050365A1
(es)
|
2004-08-02 |
2006-10-18 |
Osi Pharm Inc |
Compuestos inhibidores de multi- quinasa pirrolopirimidina aril- amino sustituidos.
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
BRPI0516242B1
(pt)
*
|
2004-10-21 |
2014-10-07 |
Dow Agrosciences Llc |
Compostos tieno-pirimidina com atividade fungicida, bem como composição fungicida e método para o controle ou prevenção de ataque fúngico
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
US7674822B2
(en)
|
2004-11-24 |
2010-03-09 |
Wyeth |
PTP1b inhibitors
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
US7582634B2
(en)
|
2005-02-18 |
2009-09-01 |
Wyeth |
7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
US7538113B2
(en)
|
2005-02-18 |
2009-05-26 |
Wyeth |
4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
US7534796B2
(en)
|
2005-02-18 |
2009-05-19 |
Wyeth |
Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
|
US7531542B2
(en)
|
2005-05-18 |
2009-05-12 |
Wyeth |
Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
|
CN101248080B
(zh)
|
2005-05-20 |
2012-09-05 |
梅特希尔基因公司 |
Vegf受体和hgf受体信号的抑制剂
|
WO2008041053A2
(en)
|
2005-05-20 |
2008-04-10 |
Methylgene, Inc. |
Inhibitors of vegf receptor and hgf receptor signaling
|
US7582636B2
(en)
|
2005-05-26 |
2009-09-01 |
Wyeth |
Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
|
KR20080026654A
(ko)
|
2005-07-14 |
2008-03-25 |
아스텔라스세이야쿠 가부시키가이샤 |
헤테로시클릭 야누스 키나제 3 억제제
|
EP2251341A1
(en)
|
2005-07-14 |
2010-11-17 |
Astellas Pharma Inc. |
Heterocyclic Janus kinase 3 inhibitors
|
US8921406B2
(en)
|
2005-08-21 |
2014-12-30 |
AbbVie Deutschland GmbH & Co. KG |
5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors
|
EP2270014A1
(en)
|
2005-09-22 |
2011-01-05 |
Incyte Corporation |
Azepine inhibitors of janus kinases
|
KR101391900B1
(ko)
|
2005-12-13 |
2014-05-02 |
인사이트 코포레이션 |
야누스 키나아제 억제제로서의 헤테로아릴 치환된 피롤로[2,3-b]피리딘 및 피롤로[2,3-b]피리미딘
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
WO2007125321A2
(en)
|
2006-04-25 |
2007-11-08 |
Astex Therapeutics Limited |
Purine and deazapurine derivatives as pharmaceutical compounds
|
US8227603B2
(en)
|
2006-08-01 |
2012-07-24 |
Cytokinetics, Inc. |
Modulating skeletal muscle
|
DK2069352T5
(en)
|
2006-08-02 |
2017-04-03 |
Cytokinetics Inc |
SPECIFIC CHEMICAL UNITS, COMPOSITIONS AND PROCEDURES
|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
JP5492565B2
(ja)
|
2006-12-22 |
2014-05-14 |
インサイト・コーポレイション |
Janusキナーゼ阻害剤としての置換複素環
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
EP2139478A4
(en)
|
2007-03-30 |
2010-05-05 |
Cytokinetics Inc |
CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
KR101549876B1
(ko)
|
2007-06-13 |
2015-09-03 |
인사이트 코포레이션 |
야누스 키나제 억제제(R)―3―(4―(7H―피롤로[2,3-d]피리미딘―4―일)―1H―피라졸―1―일)―3―사이클로펜틸프로판니트릴의 염
|
TWI475995B
(zh)
|
2007-09-14 |
2015-03-11 |
Janssen Pharmaceuticals Inc |
1’,3’-二取代-4-苯基-3,4,5,6-四氫-2h,1’h-〔1,4’〕聯吡啶基-2’-酮化物
|
EA019085B1
(ru)
|
2007-09-14 |
2014-01-30 |
Янссен Фармасьютикалз, Инк. |
1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны
|
ME01999B
(me)
|
2007-10-11 |
2015-05-20 |
Astrazeneca Ab |
Derivati pirolo[2,3-d]pirimidina kao inhibitori protein kinaze b
|
BRPI0820544A2
(pt)
|
2007-11-16 |
2015-06-16 |
Incyte Corp |
4-pirazolil-n-arilpirimidin-2-aminas e pirazolil-n-heteroarilpirimidin-2-aminas como inibidores de janus cinase
|
US8399449B2
(en)
|
2008-02-26 |
2013-03-19 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic derivative and use thereof
|
NZ589336A
(en)
|
2008-03-05 |
2011-12-22 |
Methylgene Inc |
Pyridine derivatives as inhibitors of protein tyrosine kinase activity
|
EP2288610B8
(en)
|
2008-03-11 |
2016-10-12 |
Incyte Holdings Corporation |
Azetidine and cyclobutane derivatives as jak inhibitors
|
US8871753B2
(en)
|
2008-04-24 |
2014-10-28 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
CA2744138C
(en)
|
2008-11-28 |
2015-08-11 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
US8765727B2
(en)
|
2009-01-23 |
2014-07-01 |
Incyte Corporation |
Macrocyclic compounds and their use as kinase inhibitors
|
AU2010246607B2
(en)
|
2009-05-12 |
2012-09-27 |
Addex Pharma S.A. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
JO2907B1
(en)
|
2009-05-12 |
2015-09-15 |
اديكس فرما اس ايه |
Pyridine derivatives 1, 2, 4 trisolo [4, 3-A] and their uses as positive LLs for 2MGLUR receptors
|
ES2487542T3
(es)
|
2009-05-22 |
2014-08-21 |
Incyte Corporation |
Derivados de N-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como inhibidores de cinasas Janus
|
NZ596374A
(en)
|
2009-05-22 |
2014-01-31 |
Incyte Corp |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
US8624040B2
(en)
|
2009-06-22 |
2014-01-07 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
CA2765678A1
(en)
|
2009-06-22 |
2010-12-29 |
Christopher Blackburn |
Substituted hydroxamic acids and uses thereof
|
US9249145B2
(en)
|
2009-09-01 |
2016-02-02 |
Incyte Holdings Corporation |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
CN102596960B
(zh)
|
2009-10-09 |
2016-01-20 |
因西特控股公司 |
3-(4-(7H-吡咯并[2,3-d]嘧啶-4-基)-1H-吡唑-1-基)-3-环戊基丙腈的羟基衍生物、酮基衍生物和葡糖苷酸衍生物
|
SI3050882T1
(en)
|
2010-03-10 |
2018-06-29 |
Incyte Holdings Corporation |
Piperidin-4-yl azetidine derivatives, as inhibitors of JAK1
|
TWI499421B
(zh)
|
2010-05-21 |
2015-09-11 |
Incyte Corp |
Jak抑制劑的局部製劑
|
CN102260270A
(zh)
*
|
2010-05-28 |
2011-11-30 |
中国科学院上海药物研究所 |
N-(2-甲基呋喃[2,3-d]嘧啶-4-基)丙烯酰胺、其制备方法及其用途
|
EP2643320B1
(en)
|
2010-11-08 |
2015-03-04 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
CA2814996C
(en)
|
2010-11-08 |
2019-10-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
JP5852666B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
JP5917544B2
(ja)
|
2010-11-19 |
2016-05-18 |
インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation |
Jak阻害剤としての複素環置換ピロロピリジンおよびピロロピリミジン
|
PE20140146A1
(es)
|
2010-11-19 |
2014-02-06 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
WO2012088015A2
(en)
|
2010-12-22 |
2012-06-28 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
CN103732226B
(zh)
|
2011-02-18 |
2016-01-06 |
诺瓦提斯药物公司 |
mTOR/JAK抑制剂组合疗法
|
MX357447B
(es)
|
2011-04-01 |
2018-07-10 |
Astrazeneca Ab |
Tratamiento terapeutico.
|
ES2560611T3
(es)
|
2011-06-20 |
2016-02-22 |
Incyte Holdings Corporation |
Derivados de fenil de azetidinilo, carboxamida de piridilo o pirazinilo como inhibidores de JAK
|
US9233111B2
(en)
|
2011-07-08 |
2016-01-12 |
Novartis Ag |
Pyrrolo pyrimidine derivatives
|
SG10201605707UA
(en)
|
2011-07-13 |
2016-09-29 |
Cytokinetics Inc |
Combination als therapy
|
EP2741747A1
(en)
|
2011-08-10 |
2014-06-18 |
Novartis Pharma AG |
JAK P13K/mTOR COMBINATION THERAPY
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
DK2785349T4
(da)
|
2011-11-30 |
2023-01-09 |
Astrazeneca Ab |
Kombinationsbehandling af cancer
|
WO2013102142A1
(en)
|
2011-12-28 |
2013-07-04 |
Global Blood Therapeutics, Inc. |
Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
|
EP2797597B1
(en)
|
2011-12-28 |
2020-02-26 |
Global Blood Therapeutics, Inc. |
Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
UA120834C2
(uk)
|
2012-11-15 |
2020-02-25 |
Інсайт Холдінгс Корпорейшн |
Лікарські форми руксолітинібу зі сповільненим вивільненням
|
CA3091179C
(en)
|
2013-03-06 |
2023-01-17 |
Incyte Holdings Corporation |
Processes and intermediates for making a jak inhibitor
|
EA034922B1
(ru)
|
2013-03-15 |
2020-04-07 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
US9604999B2
(en)
|
2013-03-15 |
2017-03-28 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US20140274961A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
WO2014150258A1
(en)
|
2013-03-15 |
2014-09-25 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
WO2014145040A1
(en)
|
2013-03-15 |
2014-09-18 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
AP2015008722A0
(en)
|
2013-03-15 |
2015-09-30 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
CN105579032A
(zh)
|
2013-08-07 |
2016-05-11 |
因赛特公司 |
Jak1抑制剂的持续释放剂型
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
EA202092627A1
(ru)
|
2013-11-18 |
2021-09-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
AU2014352875B2
(en)
|
2013-11-22 |
2019-10-24 |
CL BioSciences LLC |
Gastrin antagonists (eg YF476, netazepide) for treatment and prevention of osteoporosis
|
IL279202B2
(en)
|
2014-01-21 |
2023-09-01 |
Janssen Pharmaceutica Nv |
Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
|
CN109999025A
(zh)
|
2014-01-21 |
2019-07-12 |
詹森药业有限公司 |
包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
|
SI3102208T1
(sl)
|
2014-02-07 |
2021-07-30 |
Global Blood Therapeutics, Inc. |
Kristalinični polimorf proste baze 2-hidroksi-6-((2-(1-izopropil-1H-pirazol-5-IL)piridin-3-IL)metoksi)- benzaldehida
|
US9498467B2
(en)
|
2014-05-30 |
2016-11-22 |
Incyte Corporation |
Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
|
MA41841A
(fr)
|
2015-03-30 |
2018-02-06 |
Global Blood Therapeutics Inc |
Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
|
MX2018006832A
(es)
|
2015-12-04 |
2018-11-09 |
Global Blood Therapeutics Inc |
Regimenes de dosificacion de 2-hidroxi-6-((2-(1-isopropil-1h-piraz ol-5-il)-piridin-3-il)-metoxi)-benzaldehido.
|
AR108435A1
(es)
|
2016-05-12 |
2018-08-22 |
Global Blood Therapeutics Inc |
Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
|
CN107513067A
(zh)
|
2016-06-16 |
2017-12-26 |
北京赛林泰医药技术有限公司 |
含有取代环戊基的吡咯并嘧啶化合物
|
US10154992B2
(en)
*
|
2016-07-12 |
2018-12-18 |
The Regents Of The University Of California |
Compounds and methods for treating HIV infection
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
TWI778983B
(zh)
|
2016-10-12 |
2022-10-01 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
WO2019113487A1
(en)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
MA51771B1
(fr)
|
2018-01-30 |
2022-03-31 |
Incyte Corp |
Procédés de préparation de (1-(3-fluoro-2-(trifluorométhyl)isonicotinyl)pipéridine-4-one)
|
CA3091142C
(en)
|
2018-02-26 |
2023-04-11 |
Gilead Sciences, Inc. |
Substituted pyrrolizine compounds and uses thereof
|
SG11202009441PA
(en)
|
2018-03-30 |
2020-10-29 |
Incyte Corp |
Treatment of hidradenitis suppurativa using jak inhibitors
|
WO2020072377A1
(en)
|
2018-10-01 |
2020-04-09 |
Global Blood Therapeutics, Inc. |
Modulators of hemoglobin for the treatment of sickle cell disease
|
TW202039481A
(zh)
|
2018-12-21 |
2020-11-01 |
美商西建公司 |
Ripk2之噻吩并吡啶抑制劑
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|